Use these ranges and decisions with the approved drilling program, local well-control procedure, mud engineer input and operator policy. Lost-circulation diagnosis is a ranked field hypothesis until pressure, volume and geology evidence converge.
An LCM pill is not a bag count added to a tank. It is a temporary engineered fluid with a defined target, particle architecture, concentration basis, carrier rheology, mixing sequence, placement path, volume and verification plan. The safest design avoids universal recipes and documents every assumption that the field team must confirm.
Start with the treatment objective
Decide what the pill must accomplish: reduce matrix seepage, bridge a probable fracture range, seal a vugular/irregular path, strengthen a pressure-sensitive interval, or provide a diagnostic treatment response. The objective determines the material family, PSD, carrier and test method. “Stop losses” is too broad to be a design basis.
No universal recipe: concentration, particle size, volume and placement rate must follow the approved well-specific program, tool restrictions and laboratory evidence. This guide provides the engineering structure—not a pump schedule.
The design basis
| Input | What must be documented | Why it matters |
|---|---|---|
| Loss event | Rate, trend, cumulative volume, static/dynamic behavior, operating state. | Separates severity from mechanism and defines urgency. |
| Target interval | Probable depth range and confidence—not bit depth alone. | Controls placement volume and uncertainty. |
| Opening range | Estimated fracture/pore/vug range with evidence and uncertainty. | Controls PSD and morphology. |
| Placement path | Smallest restrictions, BHA/nozzles/tools, surface strainers and line-up. | Sets maximum passable material/agglomerate. |
| Fluid environment | Base fluid, salinity, pH, rheology, solids, temperature and contamination. | Controls suspension, compatibility and seal behavior. |
| Acceptance | Measured response, observation period, escalation and fallback. | Prevents subjective “looks better” decisions. |
Design the PSD as an architecture
A robust pill normally needs a coarse bridging fraction, intermediate packing particles and finer sealing material; fibres or flakes may reinforce and reduce permeability. Use the full delivered PSD rather than a product grade name. Consider attrition during mixing and selective removal at surface.
If the opening is uncertain, test more than one candidate distribution across a range of representative slot widths. Do not force a precise particle/fracture ratio onto a rough, deforming or unknown downhole feature. Published criteria are valuable starting hypotheses only within their material and test boundaries.
Set concentration on a clear basis
State concentration in unambiguous units—such as lb/bbl or kg/m³—and identify whether it refers to each component or total blend. Convert bag count to active volume using the actual mix volume, not nominal tank capacity. Include residual heel and volume changes from additions.
Higher concentration increases solids loading and can improve the probability of forming a bridge, but it also raises mixing, suspension, pumpability, tool-passability and premature-bridging risk. The optimum is formulation- and geometry-specific; “more” is not an engineering rule.
Choose and condition the carrier
The carrier must suspend the blend long enough for mixing and placement without becoming unpumpable or creating excessive pressure. Test the actual field fluid when possible. Verify rheology, density, electrical stability/emulsion behavior where relevant, fluid loss, contamination response and temperature conditioning.
A carrier that is too thin may segregate coarse material; one that is too viscous can increase pressure, resist mixing and complicate displacement. Fibres, swellables and reactive components may change rheology with time, so record conditioning and activation time.
Mixing sequence and quality control
- Confirm clean, correctly lined-up mixing volume and isolate unintended outlets.
- Condition the carrier to the approved starting properties.
- Add components in the tested sequence and controlled rate to prevent clumping or local overload.
- Maintain suitable agitation/recirculation without destructive or excessive shear.
- Reconcile every bag and final volume; sample at representative locations.
- Check homogeneity, visible agglomeration, settling, rheology/density and any program-specific QA.
- Release the pill only after the placement path and operating authority are confirmed.
The hopper can disperse some materials effectively and agglomerate others when addition is too fast. The approved formulation should define sequence, wetting and shear requirements rather than leaving them to improvisation.
Calculate volume from the placement objective
Separate three volumes: pill volume, displacement volume to the planned position, and contingency/excess defined by the program. Use the current drillstring and annular capacities, actual depths and tool configuration. State whether the target is inside the string, across the open-hole interval or at another planned location.
Do not use old tally or generic annular factors. Confirm units, measured depth versus true vertical depth relevance, pipe/BHA OD and ID, washout uncertainty, tank calibration and compressibility where material.
Protect the pill at surface without losing solids control
Decide how the treatment will interact with shakers, mud cleaner and centrifuge before pumping. Fine screens and centrifuges may remove treatment material; blanket bypass can retain drilled solids and raise ECD. Use a dedicated LCM-recovery/scalping arrangement where available or the specifically approved temporary configuration, then document restoration to normal operation.
Laboratory qualification
- Use the complete formulation at the proposed concentration and temperature.
- Test representative opening geometries/ranges, including uncertainty.
- Record time to bridge, initial spurt, cumulative loss and seal pressure.
- Inspect invasion depth, seal structure and failure/reseal behavior.
- Repeat tests and report variability—not only the best run.
- Assess passability and settling/agglomeration for the placement time.
Field verification
Define success before treatment: reduction in verified loss rate, recovered returns, stable full-cycle volume balance, acceptable pressure behavior or another program-specific endpoint. Observe long enough to distinguish a temporary restriction from a stable seal. Record cumulative fluid and material consumption, not only the immediate response.
Event basis · probable interval/confidence · formulation and supplier lots · PSD/test data · component and total concentrations · carrier properties · mixed and pumped volumes · mixing timeline · placement path · pressure/volume response · post-treatment loss rate · remaining uncertainty and next decision.
Common pill-design failures
- Starting with a favourite product instead of a defined mechanism and opening range.
- Quoting bags without concentration, active volume or component breakdown.
- Using nominal tank capacity and ignoring heel or transfer losses.
- Designing PSD for the formation but not checking BHA passability.
- Testing dry material or clean lab fluid instead of the complete field formulation.
- Adding fibres/reactive material too rapidly and creating agglomerates.
- Confusing an immediate pressure response with durable sealing.
- Failing to plan surface-equipment configuration and restoration.
Technical basis
Experimental research shows that LCM material type, PSD, concentration and deformability interact with fracture geometry. Field design therefore requires a tested formulation and explicit uncertainty rather than a universal concentration or single particle-size rule.
Common questions
What concentration should an LCM pill use?
There is no safe universal value. It depends on the formulation, opening range, carrier, passability, temperature and laboratory/field evidence in the approved program.
How is LCM pill volume calculated?
From the treatment objective and current well geometry, separating pill volume from displacement and program-defined contingency. Use verified capacities, depths and tank volume.
Can a stronger, thicker pill be worse?
Yes. Excess solids or viscosity can impair mixing, settle or agglomerate, plug tools, bridge prematurely and increase placement pressure.